Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Ruxolitinib

 Ruxolitinib: A Comprehensive Overview

Ruxolitinib is a medication used to treat certain types of blood cancers and other conditions. It is a Janus kinase (JAK) inhibitor, which means it works by blocking the activity of certain enzymes in the body that are involved in the production of blood cells.

Uses

Ruxolitinib is used to treat:

- Myelofibrosis: ruxolitinib is used to treat myelofibrosis, a type of blood cancer that affects the bone marrow

- Polycythemia vera: ruxolitinib is used to treat polycythemia vera, a type of blood disorder that causes the body to produce too many red blood cells

- Acute graft-versus-host disease: ruxolitinib is used to treat acute graft-versus-host disease, a complication that can occur after a stem cell transplant

How Ruxolitinib Works

Ruxolitinib works by:

- Inhibiting JAK1 and JAK2: ruxolitinib inhibits the activity of JAK1 and JAK2, which are enzymes involved in the production of blood cells

- Reducing inflammation: ruxolitinib reduces inflammation in the body, which can help to alleviate symptoms of certain conditions

Benefits

The benefits of ruxolitinib include:

- Reducing spleen size: ruxolitinib can reduce the size of the spleen in patients with myelofibrosis

- Improving symptoms: ruxolitinib can improve symptoms of myelofibrosis, such as fatigue, night sweats, and itching

- Increasing survival: ruxolitinib may increase survival in patients with myelofibrosis

Side Effects

Common side effects of ruxolitinib include:

- Anemia: ruxolitinib can cause anemia, which is a decrease in the number of red blood cells

- Thrombocytopenia: ruxolitinib can cause thrombocytopenia, which is a decrease in the number of platelets

- Neutropenia: ruxolitinib can cause neutropenia, which is a decrease in the number of white blood cells

- Increased risk of infection: ruxolitinib can increase the risk of infection

Precautions and Contraindications

Before taking ruxolitinib, consult your doctor if you have:

- Low blood cell counts: ruxolitinib can worsen low blood cell counts

- Infection: ruxolitinib can increase the risk of infection

- Pregnancy or breastfeeding: ruxolitinib should not be used during pregnancy or breastfeeding

Interactions

Ruxolitinib may interact with:

- Other medications: ruxolitinib may interact with other medications, including certain antibiotics and antifungal medications

- Food: ruxolitinib may interact with certain foods, including grapefruit juice

Pharmacology

Ruxolitinib is a JAK inhibitor that works by blocking the activity of certain enzymes in the body. It is available in oral formulations.

Brand Names and Availability

Ruxolitinib is marketed under the brand name Jakafi. It is available in many countries, including the United States, Europe, and Asia.

Conclusion

Ruxolitinib is a medication used to treat certain types of blood cancers and other conditions. Its ability to inhibit JAK1 and JAK2 and reduce inflammation make it a useful treatment option for patients. While generally well-tolerated, it's essential to be aware of the potential side effects and interactions associated with ruxolitinib.

Additional Resources

For more information on ruxolitinib, including user reviews and ratings, please consult reputable online sources, such as the National Institutes of Health (NIH) or the World Health Organization (WHO).

References

1. National Institutes of Health (NIH). (2022). Ruxolitinib.

2. World Health Organization (WHO). (2022). Ruxolitinib.

3. MedlinePlus. (2022). Ruxolitinib.